Works matching IS 08876924 AND DT 2008 AND VI 22 AND IP 3

Results: 37

Chronic idiopathic myelofibrosis expressing a novel type of TEL-PDGFRB chimaera responded to imatinib mesylate therapy.

Published in:

2008

By:

Tokita, K;
Maki, K;
Tadokoro, J;
Nakamura, Y;
Arai, Y;
Sasaki, K;
Eguchi-Ishimae, M;
Eguchi, M;
Mitani, K

Publication type:

Correction Notice

Choosing between stem cell therapy and drugs in myelofibrosis.

Published in:

Leukemia (08876924), 2008, v. 22, n. 3, p. 474, doi. 10.1038/sj.leu.2405080

By:

Kröger, N.;
Mesa, R. A.

Publication type:

Article

Comparison of nilotinib and imatinib inhibition of FMS receptor signaling, macrophage production and osteoclastogenesis.

Published in:

2008

By:

Brownlow, N.;
Russell, A. E.;
Saravanapavan, H.;
Wiesmann, M.;
Murray, J. M.;
Manley, P. W.;
Dibb, N. J.

Publication type:

research

Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines.

Published in:

2008

By:

Galimberti, S.;
Canestraro, M.;
Khan, R.;
Buda, G.;
Orciuolo, E.;
Guerrini, F.;
Fazzi, R.;
Maffei, R.;
Marasca, R.;
Petrini, M.

Publication type:

Letter

Platelet transfusion and survival in adults with acute leukemia.

Published in:

2008

By:

Blumberg, N.;
Heal, J. M.;
Liesveld, J. L.;
Phillips, G. L.;
Rowe, J. M.

Publication type:

Letter

Chromosomal localization of DNA methylation in small B-cell lymphoma.

Published in:

2008

By:

Taylor, K. H.;
Rahmatpanah, F.;
Davis, J. W.;
Caldwell, C. W.

Publication type:

Letter

The immunomodulatory drug Leflunomide inhibits cell cycle progression of B-CLL cells.

Published in:

2008

By:

Ringshausen, I.;
Oelsner, M.;
Bogner, C.;
Peschel, C.;
Decker, T.

Publication type:

Letter

Non-specific amplification of patient-specific Ig/TCR gene rearrangements depends on the time point during therapy: implications for minimal residual disease monitoring.

Published in:

2008

By:

van der Velden, V. H. J.;
Wijkhuijs, J. M.;
van Dongen, J. J. M.

Publication type:

Letter

Recurrent in-frame insertion in C/EBPα TAD2 region is a polymorphism without prognostic value in AML.

Published in:

2008

By:

Biggio, V.;
Renneville, A.;
Nibourel, O.;
Philippe, N.;
Terriou, L.;
Roumier, C.;
Amouyel, P.;
Cottel, D.;
Castaigne, S.;
Dombret, H.;
Thomas, X.;
Fenaux, P.;
Preudhomme, C.

Publication type:

Letter

Multiple forms of nuclear p53 formed in human Raji and MEC1 cells treated with fludarabine.

Published in:

2008

By:

Henrich, S.;
Christopherson, R. I.

Publication type:

Letter

NCOA3, a new fusion partner for MOZ/MYST3 in M5 acute myeloid leukemia.

Published in:

2008

By:

Esteyries, S.;
Perot, C.;
Adelaide, J.;
Imbert, M.;
Lagarde, A.;
Pautas, C.;
Olschwang, S.;
Birnbaum, D.;
Chaffanet, M.;
Mozziconacci, M.-J.

Publication type:

Letter

MassARRAY assay: a more accurate method for JAK2V617F mutation detection in Chinese patients with myeloproliferative disorders.

Published in:

2008

By:

Fu, J.-F.;
Shi, J.-Y.;
Zhao, W.-L.;
Li, G.;
Pan, Q.;
Li, J.-M.;
Hu, J.;
Shen, Z.-X.;
Jin, J.;
Chen, F.-Y.;
Chen, S.-J.

Publication type:

Letter

CREB regulates Meis1 expression in normal and malignant hematopoietic cells.

Published in:

2008

By:

Esparza, S. D.;
Chang, J.;
Shankar, D. B.;
Zhang, B.;
Nelson, S. F.;
Sakamoto, K. M.

Publication type:

Letter

Mcl-1 and anticancer vaccination: identification of an HLA-A2-restricted epitope.

Published in:

2008

By:

Andersen, R. S.;
Wenandy, L.;
Sørensen, R. B.;
thor Straten, P.;
Andersen, M. H.

Publication type:

Letter

No role for CXCL12–G801A polymorphism in the development of extramedullary disease in acute myeloid leukemia.

Published in:

2008

By:

Ponziani, V.;
Mannelli, F.;
Bartalucci, N.;
Gianfaldoni, G.;
Leoni, F.;
Antonioli, E.;
Guglielmelli, P.;
Ciolli, S.;
Bosi, A.;
Vannucchi, A. M.

Publication type:

Letter

A novel cytogenetic aberration found in stem cell leukemia/lymphoma syndrome.

Published in:

2008

By:

Shvidel, L.;
Sigler, E.;
Vorst, E.;
Feldberg, E.;
Voskoboinic, N.;
Shtalrid, M.;
Berrebi, A.

Publication type:

Letter

Pulmonary arterial hypertension in primary myelofibrosis is common and associated with an altered angiogenic status.

Published in:

2008

By:

Cortelezzi, A.;
Gritti, G.;
Del Papa, N.;
Pasquini, M. C.;
Calori, R.;
Gianelli, U.;
Cortiana, M.;
Parati, G.;
Onida, F.;
Sozzi, F.;
Vener, C.;
Bianchi, P.;
Deliliers, G. L.

Publication type:

Letter

Mesenchymal stem cells for graft-versus-host disease: a double edged sword?

Published in:

Leukemia (08876924), 2008, v. 22, n. 3, p. 463, doi. 10.1038/leu.2008.25

By:

Vianello, F.;
Dazzi, F.

Publication type:

Article

Acute myeloid leukemia-targeted toxins kill tumor cells by cell type-specific mechanisms and synergize with TRAIL to allow manipulation of the extent and mechanism of tumor cell death.

Published in:

2008

By:

Horita, H.;
Frankel, A. E.;
Thorburn, A.

Publication type:

Letter

Chemokine-mobilized adult stem cells; defining a better hematopoietic graft.

Published in:

2008

By:

Pelus, L. M.;
Fukuda, S.

Publication type:

journal article

HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera.

Published in:

Leukemia (08876924), 2008, v. 22, n. 3, p. 578, doi. 10.1038/sj.leu.2405050

By:

Menier, C.;
Guillard, C.;
Cassinat, B.;
Carosella, E. D.;
Rouas-Freiss, N.

Publication type:

Article

Base excision repair dysfunction in a subgroup of patients with myelodysplastic syndrome.

Published in:

Leukemia (08876924), 2008, v. 22, n. 3, p. 551, doi. 10.1038/sj.leu.2405055

By:

Jankowska, A. M.;
Gondek, L. P.;
Szpurka, H.;
Nearman, Z. P.;
Tiu, R. V.;
Maciejewski, J. P.

Publication type:

Article

T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus.

Published in:

2008

By:

Hagenbeek, T. J.;
Spits, H.

Publication type:

journal article

Subcellular distribution of p210<sup>BCR-ABL</sup> in CML cell lines and primary CD34<sup>+</sup> CML cells.

Published in:

Leukemia (08876924), 2008, v. 22, n. 3, p. 559, doi. 10.1038/sj.leu.2405057

By:

Patel, H.;
Marley, S. B.;
Greener, L.;
Gordon, M. Y.

Publication type:

Article

Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells.

Published in:

Leukemia (08876924), 2008, v. 22, n. 3, p. 585, doi. 10.1038/sj.leu.2405058

By:

Pallasch, C. P.;
Schwamb, J.;
Königs, S.;
Schulz, A.;
Debey, S.;
Kofler, D.;
Schultze, J. L.;
Hallek, M.;
Ultsch, A.;
Wendtner, C.-M.

Publication type:

Article

Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein–Barr virus infection.

Published in:

Leukemia (08876924), 2008, v. 22, n. 3, p. 620, doi. 10.1038/sj.leu.2405059

By:

Takakuwa, T.;
Tresnasari, K.;
Rahadiani, N.;
Miwa, H.;
Daibata, M.;
Aozasa, K.

Publication type:

Article

Targeting 14-3-3 sensitizes native and mutant BCR-ABL to inhibition with U0126, rapamycin and Bcl-2 inhibitor GX15-070.

Published in:

2008

By:

Dong, S.;
Kang, S.;
Lonial, S.;
Khoury, H. J.;
Viallet, J.;
Chen, J.

Publication type:

journal article

Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.

Published in:

2008

By:

Raad, I. I.;
Hanna, H. A.;
Boktour, M.;
Jiang, Y.;
Torres, H. A.;
Afif, C.;
Kontoyiannis, D. P.;
Hachem, R. Y.

Publication type:

journal article

The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy.

Published in:

2008

By:

Ge, Y.;
LaFiura, K. M.;
Dombkowski, A. A.;
Chen, Q.;
Payton, S. G.;
Buck, S. A.;
Salagrama, S.;
Diakiw, A. E.;
Matherly, L. H.;
Taub, J. W.

Publication type:

journal article

MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell lines.

Published in:

2008

By:

Nagel, S.;
Meyer, C.;
Quentmeier, H.;
Kaufmann, M.;
Drexler, H. G.;
MacLeod, R. A. F.

Publication type:

journal article

Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.

Published in:

Leukemia (08876924), 2008, v. 22, n. 3, p. 487, doi. 10.1038/sj.leu.2405068

By:

Matutes, E.;
Oscier, D.;
Montalban, C.;
Berger, F.;
Callet-Bauchu, E.;
Dogan, A.;
Felman, P.;
Franco, V.;
Iannitto, E.;
Mollejo, M.;
Papadaki, T.;
Remstein, E. D.;
Salar, A.;
Solé, F.;
Stamatopoulos, K.;
Thieblemont, C.;
Traverse-Glehen, A.;
Wotherspoon, A.;
Coiffier, B.;
Piris, M. A.

Publication type:

Article

Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes.

Published in:

Leukemia (08876924), 2008, v. 22, n. 3, p. 530, doi. 10.1038/sj.leu.2405069

By:

Della Porta, M. G.;
Malcovati, L.;
Rigolin, G. M.;
Rosti, V.;
Bonetti, E.;
Travaglino, E.;
Boveri, E.;
Gallì, A.;
Boggi, S.;
Ciccone, M.;
Pramparo, T.;
Mazzini, G.;
Invernizzi, R.;
Lazzarino, M.;
Cazzola, M.

Publication type:

Article

A prognostic score for patients with lower risk myelodysplastic syndrome.

Published in:

Leukemia (08876924), 2008, v. 22, n. 3, p. 538, doi. 10.1038/sj.leu.2405070

By:

Garcia-Manero, G.;
Shan, J.;
Faderl, S.;
Cortes, J.;
Ravandi, F.;
Borthakur, G.;
Wierda, W. G.;
Pierce, S.;
Estey, E.;
Liu, J.;
Huang, X.;
Kantarjian, H.

Publication type:

Article

Re-expression of DNA methylation-silenced CD44 gene in a resistant NB4 cell line: rescue of CD44-dependent cell death by cAMP.

Published in:

Leukemia (08876924), 2008, v. 22, n. 3, p. 511, doi. 10.1038/sj.leu.2405071

By:

Abecassis, I.;
Maes, J.;
Carrier, J.-L.;
Hillion, J.;
Goodhardt, M.;
Medjber, K.;
Wany, L.;
Lanotte, M.;
Karniguian, A.

Publication type:

Article

Bone marrow fibrosis in childhood acute lymphoblastic leukemia correlates to biological factors, treatment response and outcome.

Published in:

Leukemia (08876924), 2008, v. 22, n. 3, p. 504, doi. 10.1038/sj.leu.2405072

By:

Norén-Nyström, U.;
Roos, G.;
Bergh, A.;
Botling, J.;
Lönnerholm, G.;
Porwit, A.;
Heyman, M.;
Forestier, E.

Publication type:

Article

Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies.

Published in:

Leukemia (08876924), 2008, v. 22, n. 3, p. 544, doi. 10.1038/sj.leu.2405076

By:

Huang, T.-C.;
Ko, B.-S.;
Tang, J.-L.;
Hsu, C.;
Chen, C.-Y.;
Tsay, W.;
Huang, S.-Y.;
Yao, M.;
Chen, Y.-C.;
Shen, M.-C.;
Wang, C.-H.;
Tien, H.-F.

Publication type:

Article

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: outcome of a pilot clinical study.

Published in:

Leukemia (08876924), 2008, v. 22, n. 3, p. 593, doi. 10.1038/sj.leu.2405090

By:

Ning, H.;
Yang, F.;
Jiang, M.;
Hu, L.;
Feng, K.;
Zhang, J.;
Yu, Z.;
Li, B.;
Xu, C.;
Li, Y.;
Wang, J.;
Hu, J.;
Lou, X.;
Chen, H.

Publication type:

Article